FSGS is the third-leading cause of ESRD in the US with an increasing incidence in recent years. Inheritance may be AD or AR, with AD conditions having a less severe and later onset phenotype and often exhibiting incomplete penetrance. Mutations have been described in multiple genes. Genetic testing for familial FSGS has moved a step closer with the advent of next-generation sequencing although precisely when and how it may be useful remains a challenge.